p27 activators are a varied class of chemical compounds that focus on the upregulation or stabilization of the p27 protein, a cyclin-dependent kinase inhibitor that plays a crucial role in regulating the cell cycle. The chemical agents in this category can range from small organic molecules to complex compounds and include substances like retinoic acid, indoles, and flavonoids such as quercetin. Some p27 activators function by inhibiting the degradation pathways for the protein, thereby increasing its intracellular levels. For example, proteasome inhibitors like MG132 can lead to the stabilization of p27 by blocking its degradation. Others, like retinoic acid, can stimulate the transcription of the p27 gene itself.
The mechanisms by which these activators operate can be equally complex and diverse. For instance, some p27 activators, like butyrate, affect the histone deacetylase (HDAC) activity, leading to changes in chromatin structure and subsequently facilitating the transcription of the p27 gene. Another angle of activation can be through signaling pathways that culminate in the activation or stabilization of p27. For example, compounds that inhibit mTOR signaling could result in p27 activation due to the crosstalk between these two cellular pathways. The presence of other signaling molecules, intracellular pH, and various stress conditions can also modulate the effectiveness of these activators. Thus, the class of p27 activators represents a broad spectrum of chemicals that interact with a complex network of cellular pathways, underscoring the intricacy of cell cycle regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of mTOR, leading to an increase in p27 expression and cell cycle arrest. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
An antimetabolite used in cancer therapy that increases p27 levels. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A phytoestrogen that can upregulate p27 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase that elevates p27 levels. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
A polyphenolic compound that induces p27 through the activation of p53. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A derivative of vitamin A known to induce p27 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, leading to an increase in p27 levels. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which can lead to the accumulation of p27. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
An inhibitor of topoisomerase II that has been shown to upregulate p27. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent inhibitor of protein kinases, leading to increased p27 levels. | ||||||